Manitex Capital Inc. (TSXV:MNX)
Canada · Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
Manitex Capital Company Description
Manitex Capital Inc. focuses on acquiring interests in life sciences, and sustainable products/technologies companies. It also holds a portfolio of marketable securities. Manitex Capital Inc. is headquartered in Kirkland, Canada.
Manitex Capital Inc.
| Country | Canada |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 15 |
| CEO | Steven Saviuk |
Contact Details
Address: 16667 Hymus Boulevard Kirkland, H9H 4R9 Canada |
Stock Details
| Ticker Symbol | MNX |
| Exchange | TSX Venture Exchange |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA56342H2000 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Steven Saviuk CA | Chairman, President and Chief Executive Officer |
| Helen Saviuk CA | Chief Financial Officer and Director |
| Ronald S. Perry CA, CPA | Secretary |
| Kristof Biniecki Ph.D. | Vice President of Scientific Affairs - Valeo Pharma Inc |
| Marc F. Leger | Executive Vice President of Commercial Operations - Valeo Pharma Inc |
| Nathalie Therrien | Vice-President of QA and Regulatory Affairs - Valeo Pharma Inc. |
| Luc Mainville M.B.A. | Senior Vice President and Chief Financial Officer of Valeo Pharma Inc |